Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.75 AUD | +0.64% | -3.06% | -22.76% |
Jun. 03 | Swissmedic Grants Mayne Pharma Group Expanded Kapanol Dosage Approvals in Switzerland | MT |
May. 24 | Mayne Pharma Reiterates H2 FY24 Outlook in Wake of Change Healthcare Cyberattack | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.76% | 252M | |
+20.14% | 43.3B | |
+25.03% | 22.22B | |
+16.89% | 15.43B | |
+23.10% | 14.48B | |
+57.58% | 12.72B | |
-0.05% | 6.79B | |
-10.99% | 6.71B | |
-8.87% | 5.73B | |
+12.71% | 5.5B |
- Stock Market
- Equities
- MYX Stock
- News Mayne Pharma Group Limited
- Lupin Gets US FDA Nod for Doxycycline Hyclate Delayed-Release Tablets